| MeSH term | MeSH ID | Detail |
|---|---|---|
| Osteoarthritis, Knee | D020370 | 13 associated lipids |
| Prosthesis-Related Infections | D016459 | 7 associated lipids |
| Fractures, Stress | D015775 | 2 associated lipids |
| Osteoporosis, Postmenopausal | D015663 | 4 associated lipids |
| Thyroid Diseases | D013959 | 8 associated lipids |
| Carcinoma, Ductal, Breast | D018270 | 19 associated lipids |
| Myocardial Ischemia | D017202 | 11 associated lipids |
| Paraneoplastic Syndromes | D010257 | 4 associated lipids |
| Sepsis | D018805 | 11 associated lipids |
| Periodontal Pocket | D010514 | 9 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Choe CH et al. | Transmembrane protein 173 inhibits RANKL-induced osteoclast differentiation. | 2015 | FEBS Lett. | pmid:25728277 |
| de Molon RS et al. | OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice. | 2015 | J. Bone Miner. Res. | pmid:25727550 |
| pmid:25724681 | ||||
| Nagy V and Penninger JM | The RANKL-RANK Story. | 2015 | Gerontology | pmid:25720990 |
| pmid:25708645 | ||||
| pmid:25694056 | ||||
| Han J et al. | [Determination of bone metabolic marker levels in perio-implant crevicular fluid and analysis of dental implants stability by resonance frequency in the early stage of healing]. | 2015 | Beijing Da Xue Xue Bao | pmid:25686326 |
| Yang X et al. | Effects of TGF-β1 on OPG/RANKL expression of cementoblasts and osteoblasts are similar without stress but different with mechanical compressive stress. | 2015 | ScientificWorldJournal | pmid:25685846 |
| pmid:25684548 | ||||
| Chung CP et al. | A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study. | 2015 | Int J Mol Sci | pmid:25679449 |
| Yamamoto N et al. | Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase. | Prostaglandins Other Lipid Mediat. | pmid:25677506 | |
| pmid:25663522 | ||||
| pmid:25660312 | ||||
| Dumnicka P et al. | Osteoprotegerin, trail and osteoprotegerin/trail ratio in patients at early phase of acute pancreatitis. | 2014 | Folia Med Cracov | pmid:25648306 |
| HaDuong JH et al. | Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis. | 2015 | Int. J. Cancer | pmid:25648303 |
| pmid:25645361 | ||||
| pmid:25643339 | ||||
| Shi W et al. | Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes. | 2014 | Biosci Trends | pmid:25641178 |
| Higgs JT et al. | Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. | 2015 | Mol. Cancer Res. | pmid:25636966 |
| Lanza D et al. | Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells. | 2015 | PLoS ONE | pmid:25635832 |
| pmid:25634035 | ||||
| pmid:25633918 | ||||
| Dale MD et al. | Bone-remodeling transcript levels are independent of perching in end-of-lay white leghorn chickens. | 2015 | Int J Mol Sci | pmid:25625518 |
| pmid:25618600 | ||||
| pmid:25618371 | ||||
| pmid:25609157 | ||||
| pmid:25607338 | ||||
| Ottewell PD et al. | OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone. | 2015 | Int. J. Cancer | pmid:25603921 |
| Son GY et al. | Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells. | 2015 | J. Dent. Res. | pmid:25595364 |
| pmid:25589510 | ||||
| pmid:25585925 | ||||
| pmid:25585180 | ||||
| Wang F et al. | Association analysis between g.18873C>T and g.27522G>A genetic polymorphisms of OPG and bone mineral density in Chinese postmenopausal women. | 2014 | Biomed Res Int | pmid:25580430 |
| Oostra DR et al. | Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. | 2015 | Mol. Cell. Endocrinol. | pmid:25575458 |
| pmid:25572286 | ||||
| pmid:25557611 | ||||
| Ostrowska Z et al. | Selected adipose tissue hormones, bone metabolism, osteoprotegerin and receptor activator of nuclear factor-kB ligand in postmenopausal obese women. | 2014 | Endokrynol Pol | pmid:25554611 |
| pmid:25554597 | ||||
| Fu Y et al. | Involvement of the Ca²⺠signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation. | 2015 | J. Vet. Sci. | pmid:25549213 |
| Shen A et al. | Role of osteoprotegerin and its gene polymorphisms in the occurrence of left ventricular hypertrophy in essential hypertensive patients. | 2014 | Medicine (Baltimore) | pmid:25546658 |
| pmid:25539196 | ||||
| pmid:25536123 | ||||
| pmid:25532817 | ||||
| pmid:25518897 | ||||
| Lin TH et al. | NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. | 2015 | Tissue Eng Part A | pmid:25518013 |
| MacMillan AK et al. | Similar healthy osteoclast and osteoblast activity on nanocrystalline hydroxyapatite and nanoparticles of tri-calcium phosphate compared to natural bone. | 2014 | Int J Nanomedicine | pmid:25506216 |
| pmid:25502845 | ||||
| pmid:25499997 | ||||
| pmid:25498379 | ||||
| pmid:25494659 | ||||
| Kadlub N et al. | The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. | 2015 | J. Bone Miner. Res. | pmid:25491283 |
| Nash LA et al. | Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway. | 2015 | Mol Nutr Food Res | pmid:25488131 |
| pmid:25486133 | ||||
| pmid:25475457 | ||||
| pmid:25475449 | ||||
| Jiang Y et al. | Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling. | 2014 | J Transl Med | pmid:25471933 |
| pmid:25464125 | ||||
| pmid:25461399 | ||||
| Rao M et al. | Osteoclasts are dispensable for hematopoietic progenitor mobilization by granulocyte colony-stimulating factor in mice. | 2015 | Exp. Hematol. | pmid:25461255 |
| pmid:25460576 | ||||
| pmid:25453890 | ||||
| pmid:25450818 | ||||
| pmid:25446507 | ||||
| pmid:25446307 | ||||
| pmid:25446166 | ||||
| Estanislau IM et al. | Pleiotropic effects of statins on the treatment of chronic periodontitis--a systematic review. | 2015 | Br J Clin Pharmacol | pmid:25444240 |
| pmid:25442456 | ||||
| pmid:25438102 | ||||
| pmid:25433965 | ||||
| pmid:25415928 | ||||
| pmid:25406873 | ||||
| Titanji K et al. | Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. | 2014 | PLoS Pathog. | pmid:25393853 |
| Akiyama N et al. | Limitation of immune tolerance-inducing thymic epithelial cell development by Spi-B-mediated negative feedback regulation. | 2014 | J. Exp. Med. | pmid:25385757 |
| pmid:25383958 | ||||
| Lv Y et al. | Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits. | 2014 | BMC Musculoskelet Disord | pmid:25377946 |
| D'Abramo A et al. | Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis. | 2014 | Mediators Inflamm. | pmid:25374442 |
| pmid:25373482 | ||||
| Samir SM and Malek HA | Effect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages. | 2014 | J. Physiol. Pharmacol. | pmid:25371528 |
| pmid:25362655 | ||||
| pmid:25354898 | ||||
| Arrigoni C et al. | Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases. | 2014 | Mol. Cancer | pmid:25335447 |
| pmid:25333856 | ||||
| pmid:25323794 | ||||
| pmid:25323324 | ||||
| Lee CJ et al. | Serum osteoprotegerin is associated with arterial stiffness assessed according to the cardio-ankle vascular index in hypertensive patients. | 2015 | J. Atheroscler. Thromb. | pmid:25318352 |
| pmid:25316684 | ||||
| Cardelli M and Aubin JE | ERRγ is not required for skeletal development but is a RUNX2-dependent negative regulator of postnatal bone formation in male mice. | 2014 | PLoS ONE | pmid:25313644 |
| Movérare-Skrtic S et al. | Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. | 2014 | Nat. Med. | pmid:25306233 |
| Holt V et al. | Identification of a subpopulation of marrow MSC-derived medullary adipocytes that express osteoclast-regulating molecules: marrow adipocytes express osteoclast mediators. | 2014 | PLoS ONE | pmid:25302610 |
| Moran CS et al. | Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse. | 2014 | Arterioscler. Thromb. Vasc. Biol. | pmid:25301844 |
| Schündeln MM et al. | Impairment of bone health in pediatric patients with hemolytic anemia. | 2014 | PLoS ONE | pmid:25299063 |
| Nascimento MM et al. | Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease. | 2014 | Braz. J. Med. Biol. Res. | pmid:25296363 |
| pmid:25292314 | ||||
| Kuroyanagi G et al. | Down-regulation by resveratrol of basic fibroblast growth factor-stimulated osteoprotegerin synthesis through suppression of Akt in osteoblasts. | 2014 | Int J Mol Sci | pmid:25290095 |
| Brabnikova-Maresova K et al. | Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis. | 2014 | Arthritis Res. Ther. | pmid:25280749 |
| pmid:25280574 | ||||
| pmid:25274266 | ||||
| pmid:25270538 | ||||
| Recker EN et al. | A cross-sectional assessment of biomarker levels around implants versus natural teeth in periodontal maintenance patients. | 2015 | J. Periodontol. | pmid:25269523 |
| pmid:25268406 |